Literature DB >> 32047769

Prolonged surveillance of colorectal cancer patients after curative surgeries beyond five years of follow-up.

Lingheng Kong1, Jianhong Peng1, Jibin Li1, Fulong Wang1, Cong Li1, Peirong Ding1, Liren Li1, Gong Chen1, Xiaojun Wu1, Zhenhai Lu1, Yujing Fang1, Zhizhong Pan1, Desen Wan1.   

Abstract

BACKGROUND: Local or distant recurrence may develop beyond 5 years after radical resection for colorectal cancer (CRC). There is little evidence of a pattern of recurrence after the routinely recommended 5 years of follow-up. We aimed to investigate the efficacy of the prolonged follow-up beyond 5 years.
METHODS: We retrospectively analyzed clinical and survival data of 1,054 CRC patients who underwent radical resections from 1980 to 1996 in our center. The prolonged surveillance was recommended for each patient with a duration of over 20 years.
RESULTS: The follow-up rates of 5, 10, 15, and 20 years were 92.6%, 86.9%, 82.3% and 76.8%, respectively. Overall survival (OS) rates of 5, 10, 15, and 20 years were 68.4%, 57.7%, 52.6% and 45.0%, respectively. Totally, 112 (10.6%) patients developed local recurrences and 174 (16.5%) patients developed distant metastases. The 99.2% postoperative local recurrences and distant metastases occurred within the first 15 years of surveillance. Survival differed between four age groups. Local recurrence was mainly diagnosed among rectal cancer patients, especially in those with lower-third rectal cancer. Metastases were commonly found in the liver and lungs. Patients with colon cancer and stage I/II manifested significantly longer OS than patients with rectal cancer and stage III/IV (both P<0.001).
CONCLUSIONS: In this study, postoperative local recurrences and distant metastases was rarely found after 15 years of enhanced surveillance, which indicated a "true cure" if the patient did not develop recurrences and metastases after 15 years. 2019 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  Colorectal cancer (CRC); long-term follow-up; radical resection

Year:  2019        PMID: 32047769      PMCID: PMC7011595          DOI: 10.21037/atm.2019.10.39

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  16 in total

Review 1.  Follow-up after curative resection of colorectal cancer: a meta-analysis.

Authors:  Joe J Tjandra; Miranda K Y Chan
Journal:  Dis Colon Rectum       Date:  2007-11       Impact factor: 4.585

Review 2.  Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer.

Authors:  Douglas K Rex; Charles J Kahi; Bernard Levin; Robert A Smith; John H Bond; Durado Brooks; Randall W Burt; Tim Byers; Robert H Fletcher; Neil Hyman; David Johnson; Lynne Kirk; David A Lieberman; Theodore R Levin; Michael J O'Brien; Clifford Simmang; Alan G Thorson; Sidney J Winawer
Journal:  Gastroenterology       Date:  2006-05       Impact factor: 22.682

Review 3.  Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999.

Authors:  C C Compton; L P Fielding; L J Burgart; B Conley; H S Cooper; S R Hamilton; M E Hammond; D E Henson; R V Hutter; R B Nagle; M L Nielsen; D J Sargent; C R Taylor; M Welton; C Willett
Journal:  Arch Pathol Lab Med       Date:  2000-07       Impact factor: 5.534

4.  Repeat pulmonary resection for isolated recurrent lung metastases yields results comparable to those after first pulmonary resection in colorectal cancer.

Authors:  Yutaka Ogata; Keiko Matono; Akihiro Hayashi; Shinzo Takamor; Keisuke Miwa; Teruo Sasatomi; Nobuya Ishibashi; Seiichiro Shida; Kazuo Shirouzu
Journal:  World J Surg       Date:  2005-03       Impact factor: 3.352

Review 5.  Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials.

Authors:  Andrew G Renehan; Matthias Egger; Mark P Saunders; Sarah T O'Dwyer
Journal:  BMJ       Date:  2002-04-06

Review 6.  Prognosis and response to therapy in colorectal cancer.

Authors:  J Walker; P Quirke
Journal:  Eur J Cancer       Date:  2002-05       Impact factor: 9.162

7.  Follow-up of patients with colorectal cancer. A meta-analysis.

Authors:  D J Bruinvels; A M Stiggelbout; J Kievit; H C van Houwelingen; J D Habbema; C J van de Velde
Journal:  Ann Surg       Date:  1994-02       Impact factor: 12.969

Review 8.  Surgical therapy of liver metastases.

Authors:  Boris Kuvshinoff; Yuman Fong
Journal:  Semin Oncol       Date:  2007-06       Impact factor: 4.929

9.  Surveillance after curative colon cancer resection: practice patterns of surgical subspecialists.

Authors:  K S Virgo; T P Wade; W E Longo; M A Coplin; A M Vernava; F E Johnson
Journal:  Ann Surg Oncol       Date:  1995-11       Impact factor: 5.344

Review 10.  Hepatectomy for resectable colorectal cancer metastases--indicators of prognosis, definition of resectability, techniques and outcomes.

Authors:  Renato Lupinacci; Christophe Penna; Bernard Nordlinger
Journal:  Surg Oncol Clin N Am       Date:  2007-07       Impact factor: 3.495

View more
  5 in total

1.  Effects of Inflammatory Response Genes on the Immune Microenvironment in Colorectal Cancer.

Authors:  YaChen Wang; Luping Zhang; Guanghuan Shi; Mingqing Liu; Weidan Zhao; Yingli Zhang; Ying Wang; Nan Zhang
Journal:  Front Genet       Date:  2022-04-08       Impact factor: 4.772

2.  PITPNC1 fuels radioresistance of rectal cancer by inhibiting reactive oxygen species production.

Authors:  Yujing Tan; Ruoyang Shao; Jingyu Li; Hongyun Huang; Yanru Wang; Menglan Zhang; Jianyun Cao; Junde Zhang; Junguo Bu
Journal:  Ann Transl Med       Date:  2020-02

3.  Case report of surgical management of a locally invasive colostomy adenocarcinoma.

Authors:  Lindsay Pearson; Daniel M Chopyk; Seth A Rosen
Journal:  Int J Surg Case Rep       Date:  2020-06-20

4.  Prolonged follow-up of colorectal cancer patients after 5 years: to follow or not to follow, that is the question (and how)!

Authors:  Raul Caso; Anne Fabrizio; Michael Sosin
Journal:  Ann Transl Med       Date:  2020-03

5.  Overexpression of UBE2M through Wnt/β-Catenin signaling is associated with poor prognosis and chemotherapy resistance in colorectal cancer.

Authors:  Jianmin Xu; Guoqiang Lv; Binghua Xu; Bin Jiang
Journal:  Transl Cancer Res       Date:  2020-09       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.